Enhances Property and Casualty Actuarial and Compliance Offerings within Insurance Practice Adds 25 Billable Professionals, Including One Senior Managing Director […]
NEW YORK, March 04, 2024 (GLOBE NEWSWIRE) — Y-mAbs Therapeutics, Inc. (the “Company” or “Y-mAbs”) (Nasdaq: YMAB), a commercial-stage biopharmaceutical […]